难治性院外心脏骤停中的血清乳酸:Prague OHCA 研究的救后分析
本研究为Prague OHCA随机研究(NCT01511666)的救后分析,评估难治性院外心脏骤停患者接受ECPR(ECPR组)或传统复苏且院前达到自主循环恢复(ROSC组)时的血清乳酸水平。入院时及最初24小时内每4小时测定乳酸,分析其与心脏骤停后180天内最佳脑功能分类(CPC)评分的关系。ECPR组92例(中位年龄58.5岁,83%男性)中26%获得良好神经预后;ROSC组82例(中位年龄55岁,83%男性)中59%获得良好神经预后。ECPR组乳酸可区分良好预后患者,但ROSC组不一致;入院时ECPR组乳酸>14.0 mmol/L(特异性87.5%,敏感性54.4%)、ROSC组>10.8 mmol/L(特异性83%,敏感性41.2%)预测不良预后。结论认为乳酸在ECPR组与预后相关,但单次测定不足以可靠预测预后,不能单独用于指导治疗。
要点
- ECPR组92例中26%获得良好神经预后,ROSC组82例中59%获得良好神经预后。
- ECPR组入院时乳酸>14.0 mmol/L预测不良预后,特异性87.5%、敏感性54.4%。
- ROSC组入院时乳酸>10.8 mmol/L预测不良预后,特异性83%、敏感性41.2%。
- ECPR组乳酸可区分良好预后患者,ROSC组不一致。
- 单次乳酸测定不足以可靠预测预后,不能单独指导治疗。
适用人群与场景
- 难治性院外心脏骤停患者,接受ECPR(ECPR组)或传统复苏且院前达到ROSC(ROSC组)。
诊断标准与关键阈值
- 入院时ECPR组血清乳酸>14.0 mmol/L预测不良神经预后(特异性87.5%,敏感性54.4%)。
- 入院时ROSC组血清乳酸>10.8 mmol/L预测不良神经预后(特异性83%,敏感性41.2%)。
研究设计与关键结果
- 本研究为Prague OHCA随机研究(NCT01511666)的救后分析,评估难治性院外心脏骤停患者接受ECPR或传统复苏(院前ROSC)时血清乳酸与神经预后的关系。
- ECPR组92例(中位年龄58.5岁,83%男性)中26%获得良好神经预后;ROSC组82例(中位年龄55岁,83%男性)中59%获得良好神经预后。
- ECPR组乳酸可区分良好预后患者,ROSC组不一致。
- 入院时ECPR组乳酸>14.0 mmol/L(特异性87.5%,敏感性54.4%)和ROSC组>10.8 mmol/L(特异性83%,敏感性41.2%)预测不良预后。
证据类型、等级与局限
- 证据类型:随机对照试验(Prague OHCA研究,NCT01511666)的救后分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 在难治性院外心脏骤停患者中,入院后24小时内测定的血清乳酸与ECPR组预后相关,但与院前ROSC组不相关。
- 单次乳酸测定不足以可靠预测预后,不能单独用于指导治疗。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: The severity of tissue hypoxia is routinely assessed by serum lactate. We aimed to determine whether early lactate levels predict outcomes in refractory out-of-hospital cardiac arrest (OHCA) treated by conventional and extracorporeal cardiopulmonary resuscitation (ECPR).
METHODS: This study is a post-hoc analysis of a randomized Prague OHCA study (NCT01511666) assessing serum lactate levels in refractory OHCA treated by ECPR (the ECPR group) or conventional resuscitation with prehospital achieved return of spontaneous circulation (the ROSC group). Lactate concentrations measured on admission and every 4 hours (h) during the first 24 h were used to determine their relationship with the neurological outcome (the best Cerebral Performance Category score within 180 days post-cardiac arrest).
RESULTS: In the ECPR group (92 patients, median age 58.5 years, 83% male) 26% attained a favorable neurological outcome. In the ROSC group (82 patients, median age 55 years, 83% male) 59% achieved a favorable neurological outcome. In ECPR patients lactate concentrations could discriminate favorable outcome patients, but not consistently in the ROSC group. On admission, serum lactate >14.0 mmol/L for ECPR (specificity 87.5%, sensitivity 54.4%) and >10.8 mmol/L for the ROSC group (specificity 83%, sensitivity 41.2%) predicted an unfavorable outcome.
CONCLUSION: In refractory OHCA serum lactate concentrations measured anytime during the first 24 h after admission to the hospital were found to correlate with the outcome in patients treated by ECPR but not in patients with prehospital ROSC. A single lactate measurement is not enough for a reliable outcome prediction and cannot be used alone to guide treatment.
参考来源
- Dusik M, Rob D, Smalcova J, et al. Serum lactate in refractory out-of-hospital cardiac arrest: Post-hoc analysis of the Prague OHCA study. Resuscitation. 2023. PMID: 37574002. doi:10.1016/j.resuscitation.2023.109935
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。